Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05132517 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Magnesium and Cognition After Stroke

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Mar 31, 2026 to Dec 31, 2026
    • Study completion date: Sep 30, 2026 to Sep 30, 2027
    v10
  2. Primary completion date: Dec 31, 2025 to Mar 31, 2026
    • Study completion date: Jun 30, 2026 to Sep 30, 2026
    v9
  3. Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Study completion date: Jun 30, 2024 to Jun 30, 2026
    v8
  4. Start date changed from estimate of Nov 1, 2022 to Oct 26, 2022v7
  5. Start date: Oct 1, 2022 to Nov 1, 2022v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 1, 2022 to Oct 1, 2022
    • Site details revised
    v5
  2. Start date: Oct 1, 2022 to Sep 1, 2022v4
  3. Start date: May 1, 2022 to Oct 1, 2022v3
  4. Primary completion date: Jun 30, 2023 to Dec 31, 2023
    • Start date: Dec 1, 2021 to May 1, 2022
    • Study completion date: Dec 31, 2023 to Jun 30, 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients. Low serum-mg-concentrations are associated with cognitive impairments in ischemic stroke patients one month after stroke onset. It is not clear, if cognitive impairments after stroke is caused by the mg-deficiency or by the stroke itself. Until now, no studies investigating the relationship between mg-concentration, stroke severity and cognition during treatment course are available. Thus, this study aimed to investigate the relationship between mg-concentration and cognition of stroke patients.
Trial Details
NCT Number NCT05132517
Lead Sponsor BDH-Klinik Hessisch Oldendorf
Conditions
(from sponsor)		 Stroke, Cognition, Magnesium, Neurologic Disorder
Related terms Nervous System Diseases, Stroke
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov